Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Aloxiprin

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
Aloxiprin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Legal status
Legal status
Identifiers
  • aluminium 2-acetyloxybenzoate hydroxide
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC9H8Al2O7
Molar mass282.119 g·mol−1
3D model (JSmol)
  • CC(=O)OC1=CC=CC=C1C(=O)O.[O-2].[O-2].[O-2].[Al+3].[Al+3]

  • CC(=O)Oc0ccccc0C(=O)O[Al](O)OC(=O)c1ccccc1OC(=O)C
  • InChI=1S/C9H8O4.2Al.3O/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;;;;;/h2-5H,1H3,(H,11,12);;;;;/q;2*+3;3*-2
  • Key:MXCPYJZDGPQDRA-UHFFFAOYSA-N

Aloxiprin (oraluminium acetylsalicylate) is amedication used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.It is used for its properties as ananti-inflammatory,antipyretic andanalgesic drug.[2]It is a chemical compound of aluminium hydroxide andaspirin.[3][4]

Alternative names and combinations

[edit]

Contraindications

[edit]

References

[edit]
  1. ^"Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025"(pdf).Therapeutic Goods Administration (TGA). May 2025. Retrieved31 August 2025.
  2. ^MIMS."Aloxiprin".MIMS. Retrieved16 April 2011.
  3. ^Encarta."Aloxiprin".Encarta. Retrieved16 April 2011.[permanent dead link]
  4. ^CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid".J. Pharm. Pharmacol.15:56–62.doi:10.1111/j.2042-7158.1963.tb12743.x.PMID 14024235.S2CID 33366977.
  5. ^Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')".The British Journal of Clinical Practice.22 (9):392–4.PMID 4876729.
  6. ^Net Doctor UK."Askit Powders".Treatments for joint, muscle and bone conditions. Retrieved16 April 2011.
Antiplatelet drugs
Glycoprotein IIb/IIIa inhibitors
ADP receptor/P2Y12inhibitors
Prostaglandin analogue (PGI2)
COX inhibitors
Thromboxane inhibitors
Phosphodiesterase inhibitors
Other
Anticoagulants
Vitamin K antagonists
(inhibitII,VII,IX,X)
Factor Xa inhibitors
(with some II inhibition)
Heparin group/
glycosaminoglycans/
(bindantithrombin)
Direct Xa inhibitors ("xabans")
Direct thrombin (IIa) inhibitors
Other
Thrombolytic drugs/
fibrinolytics
Non-medicinal
pyrazolones /
pyrazolidines
salicylates
acetic acid derivatives
and related substances
oxicams
propionic acid
derivatives (profens)
n-arylanthranilic
acids (fenamates)
COX-2 inhibitors
(coxibs)
other
NSAID
combinations
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;withdrawn drugs;veterinary use.
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
DP2Tooltip Prostaglandin D2 receptor 2
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
EP2Tooltip Prostaglandin EP2 receptor
EP3Tooltip Prostaglandin EP3 receptor
EP4Tooltip Prostaglandin EP4 receptor
Unsorted
FP (F)Tooltip Prostaglandin F receptor
IP (I2)Tooltip Prostacyclin receptor
TP (TXA2)Tooltip Thromboxane receptor
Unsorted
Enzyme
(inhibitors)
COX
(
PTGS)
PGD2STooltip Prostaglandin D synthase
PGESTooltip Prostaglandin E synthase
PGFSTooltip Prostaglandin F synthase
PGI2STooltip Prostacyclin synthase
TXASTooltip Thromboxane A synthase
Others
Portal:


Stub icon

Thisdrug article relating to theblood andblood forming organs is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Aloxiprin&oldid=1309926675"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp